AI in Oncology Market to Reach US$ 29.08 Billion by 2033
The AI in Oncology Market is expanding rapidly as healthcare providers, technology companies, and pharmaceutical organizations adopt artificial intelligence to support cancer diagnosis, treatment planning, and precision medicine. Growing cancer incidence, increasing availability of medical imaging data, and advances in clinical analytics are creating opportunities for AI-powered oncology solutions.
The AI in Oncology Market was valued at US$ 3.62 Billion in 2025 and is projected to reach US$ 29.08 Billion by 2033, registering a CAGR of 29.75% during 2026–2033. Rising investments in digital healthcare, growing adoption of AI-enabled clinical decision support, and increased use of genomic and pathology data are expected to support market growth.
Market Overview
Artificial intelligence is increasingly being applied across oncology to analyze medical images, identify potential cancer indicators, interpret pathology findings, support biomarker discovery, and assist healthcare professionals with treatment decisions. By processing large volumes of clinical, imaging, and genomic data, AI platforms can help improve workflow efficiency and support more personalized approaches to cancer care.
The AI in Oncology Market is benefiting from the expansion of digital pathology, precision medicine programs, and data-driven cancer research. Healthcare organizations are exploring AI solutions to help manage growing diagnostic workloads, while pharmaceutical companies use computational tools to support patient stratification, biomarker identification, and clinical research. The market outlook is also influenced by advances in machine learning, deep learning, and cloud-based analytics.
The market is segmented by component into Hardware/Devices and Software & Services, and by deployment into Cloud-based and On-Premise & Hybrid. Software & Services accounted for an estimated 65%–68% share in 2025, reflecting demand for scalable analytics platforms and clinical workflow integration. Clinical Decision Support & Therapy Selection is a key high-growth application area, supported by growing interest in personalized treatment planning.
Check valuable insights in the AI in Oncology Market report. You can easily get a sample PDF of the report here: https://www.businessmarketinsights.com/sample/BMIPUB00038729
Key Market Trends
Increasing Adoption of AI-Powered Diagnostics
AI-enabled tools are being used to support the analysis of radiology images and digital pathology data. These solutions can help prioritize cases, identify patterns, and assist specialists in reviewing complex diagnostic information. As healthcare facilities expand their digital infrastructure, demand for AI applications across oncology workflows is expected to increase.
Growth in Precision Oncology
Precision oncology relies on detailed analysis of genomic, clinical, and molecular information to guide treatment decisions. AI can help integrate these data sources to identify potential biomarkers and support therapy selection. Growing interest in personalized treatment strategies is creating opportunities for oncology-focused software and analytics providers.
Expansion of Cloud-Based Platforms
Cloud-based deployment offers healthcare organizations scalability, remote access, and opportunities to integrate data across departments and research networks. These capabilities can support collaborative analysis and broader use of AI applications. Data security, governance, and interoperability remain important considerations when implementing cloud-based healthcare technologies.
Global Market Insights
North America held an estimated 40%–43% share of the AI in Oncology Market in 2025. The region benefits from established oncology infrastructure, investment in AI research, digitized medical imaging, and collaborations between healthcare providers, pharmaceutical companies, and technology developers.
Asia Pacific is the fastest-growing regional market, with an estimated 22%–25% share in 2025 and a projected CAGR of 32%–35% during 2026–2033. Healthcare digitization, investment in imaging infrastructure, expanding cancer screening programs, and government support for AI innovation are contributing to the region’s growth.
By component, Software & Services is the leading segment, supported by analytics platforms, pathology automation, clinical workflow integration, and decision-support applications. Cloud-based solutions are gaining traction as organizations seek scalable deployment options. Clinical Decision Support & Therapy Selection represents an important growth opportunity as providers increasingly evaluate tools that integrate imaging, genomic, and clinical information.
Explore the AI in Oncology industry overview for additional market insights and forecasts. https://www.businessmarketinsights.com/industry-overview/ai-in-oncology-market
Regional Analysis
North America is expected to maintain a leading position through 2033, supported by advanced cancer centers, strong research capabilities, AI investment, and growing integration of digital technologies into clinical workflows. Pharmaceutical collaborations and the availability of oncology datasets also support innovation.
Europe is advancing through healthcare digitization, cancer-screening initiatives, research collaboration, and established data governance frameworks. The adoption of AI tools across diagnostic and precision medicine programs is creating opportunities for technology developers and healthcare organizations.
Asia Pacific is projected to record the strongest growth during the forecast period. Expanding healthcare infrastructure, increasing demand for cancer diagnosis, AI investments, and the development of digital health capabilities are supporting adoption across the region.
South and Central America, the Middle East, and Africa offer additional growth opportunities as healthcare facilities modernize diagnostic services, expand specialist cancer care, and invest in digital technologies.
Key Growth Drivers and Opportunities
Rising Cancer Burden and Diagnostic Demand
Increasing demand for cancer screening, diagnosis, and treatment places pressure on radiology and pathology services. AI-powered tools can help healthcare professionals analyze large datasets and prioritize diagnostic workflows, supporting the adoption of automated analytical solutions.
Digital Pathology and Imaging Infrastructure
The growing digitization of pathology slides and medical images is creating more data for AI model development and clinical applications. Better digital infrastructure can support image analysis, workflow automation, and collaboration among healthcare professionals.
Precision Medicine and Genomic Research
AI tools can help researchers analyze complex genomic and clinical datasets, identify potential biomarkers, and support patient stratification. These capabilities create opportunities for oncology AI providers to work with pharmaceutical companies, research institutions, and cancer centers.
Clinical Decision Support and Therapy Selection
Integrated AI platforms can bring together patient histories, imaging, pathology, and genomic findings to support treatment planning. As personalized oncology advances, clinical decision support and therapy selection are expected to remain important areas for product development and investment.
Market Challenges
Data privacy requirements, interoperability barriers, and differences in healthcare information systems can complicate AI implementation. Healthcare organizations must ensure that sensitive patient information is managed appropriately and that new platforms can integrate with existing clinical workflows.
Clinical validation, trust, and regulatory requirements also influence adoption. AI systems need to demonstrate reliability and clinical usefulness, while healthcare professionals must understand how outputs should inform decisions. These considerations can affect implementation timelines and the pace of commercialization.
Competitive Landscape
The AI in Oncology Market includes healthcare technology companies, AI infrastructure providers, medical imaging businesses, and specialized oncology analytics developers. Competition is shaped by technological capabilities, clinical validation, data integration, partnerships, and the ability to incorporate solutions into healthcare workflows.
Major companies identified by Business Market Insights include IBM Corporation, NVIDIA Corporation, Siemens Healthineers AG, GE HealthCare Technologies Inc., Tempus AI, Inc., PathAI, Inc., ConcertAI, Inc., Microsoft Corporation, Digital Diagnostics Inc., and Median Technologies SA.
Companies are developing capabilities across medical imaging, clinical analytics, digital pathology, and oncology research. Collaboration among technology providers, healthcare institutions, and pharmaceutical companies remains an important route for developing and deploying AI-enabled oncology solutions.
Access the complete AI in Oncology Market report for detailed forecasts, segment analysis, regional insights, and competitive intelligence: https://www.businessmarketinsights.com/buy/BMIPUB00038729
Conclusion
The AI in Oncology Market is projected to grow from US$ 3.62 Billion in 2025 to US$ 29.08 Billion by 2033, at a CAGR of 29.75% during 2026–2033. Increasing cancer diagnostic needs, precision medicine adoption, digital pathology, and AI-enabled clinical decision support are expected to support market expansion. Software & Services and rapidly growing Asia Pacific markets are important areas to watch as healthcare organizations continue to integrate AI into cancer care and research.
Related Reading / Reports
- AI in Pharma and Biotech Market
Explore AI adoption in drug discovery, clinical research, and precision medicine. - AI in Clinical Trials Market
Review AI applications in clinical research, patient matching, and trial optimization. - Cancer Biomarkers Market
Understand market opportunities in biomarker identification and precision oncology. - Oncology Molecular Diagnostics Market
Explore developments in molecular testing and cancer diagnostics.
About Us
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Contact Us
If you have any questions about this report or would like further information, please contact us:
- Contact person: Ankit Mathur
- Email: [email protected]
- Phone: +16467917070
Press Release Source: Read the original article